Skip to content
Lower risk Medical device recall · FDA · Published December 10, 2021

Ortho-Clinical VITROS VersaTips Recall: 16% Sample Volume Error Risk

Ortho-Clinical recalls VITROS VersaTips (Catalog 6801715) due to potential 16% sample volume reduction causing inaccurate blood tests. Affected units may lead to incorrect drug dosing or false positive/negative results for infectious diseases.

🇺🇸 FDA recall #Z-0735-2022Medical deviceOrtho-Clinical ›
Take action

Contact the company

Recalling firmOrtho-Clinical Diagnostics, Inc.100 Indigo Creek Dr · Rochester, NY 14626-5101
✎ GovInfoNow plain-language explainer

Ortho-Clinical is recalling VITROS VersaTips (1000 tips per box) because some units may dispense 16% less sample volume. This could cause incorrect drug dosing or false test results for bloodborne infections if not caught. Read more at govinfonow.com/recall/61438-ortho-clinical-vitros-versatips-recall-16-sample-volume-error-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/61438-ortho-clinical-vitros-versatips-recall-16-sample-volume-error-risk · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0735-2022

Cite this page

“Ortho-Clinical VITROS VersaTips Recall: 16% Sample Volume Error Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/61438-ortho-clinical-vitros-versatips-recall-16-sample-volume-error-risk. Based on FDA recall #Z-0735-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0735-2022%22&limit=1).

The FDA announced on Dec. 10, 2021, that Ortho-Clinical Diagnostics is recalling VITROS Chemistry Products VersaTips due to shape deformities that may cause inaccurate test results. Owners should contact the company for a remedy.

How to tell if you have it

  • Brand: Ortho-Clinical
  • Product: VITROS Chemistry Products VersaTips
  • Catalog No.: 6801715
  • Lot code: 1039734
  • Units affected: 4,125

The hazard

The deformity may reduce the volume of sample or reagent dispensed by 16%. This error can lead to reduced drug dosage or false positive or negative results for bloodborne infectious disease assays when sample results are close to the cut-off value.

Context

GovInfoNow's records show Ortho-Clinical Diagnostics has had 53 other recalls since July 10, 2017. Recent recalls include calibration failures affecting VITROS LAC Slides on July 29, 2025, and VITROS Ca Slides on July 9, 2025. Other recent recalls of similar products include Bioporto ProNephro AKI Reagent Kit (May 18, 2026), Vivoo Vaginal pH Test (Nov. 22, 2025), and Vivoo Protein Test (Nov. 22, 2025).

How to tell if you have this one

Check for the catalog number 6801715 on the VersaTip box. The lot number 1039734 is also associated with this recall.

  • Brand
    Ortho-Clinical
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Your VersaTips

    Look for the catalog number 6801715 and lot number 1039734 on the box.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Domestic distribution nationwide. Foreign distribution to Canada.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 3 months after the firm started it.

1. Firm started the recall: Dec 10, 202112. FDA classified it Class II: Mar 8, 202223. Published in FDA’s Enforcement Report: Mar 16, 2022320212022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0735-2022 (December 10, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0735-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA